{
    "2021-08-16": [
        [
            {
                "time": "",
                "original_text": "国内mRNA疫苗厂商押注加强剂市场 获得批准仍有挑战",
                "features": {
                    "keywords": [
                        "mRNA",
                        "疫苗",
                        "加强剂",
                        "市场",
                        "挑战"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "西部证券：首予舍得酒业(600702.SH)“增持”评级 复星系入驻 有望带来资源加持",
                "features": {
                    "keywords": [
                        "西部证券",
                        "舍得酒业",
                        "增持",
                        "复星系",
                        "资源加持"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-08",
                "original_text": "创新药行业周报：2021年8月第二周创新药周报",
                "features": {
                    "keywords": [
                        "创新药",
                        "行业周报",
                        "2021年8月第二周"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：关注CXO新秀 重点推荐皓元医药、诺泰生物等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "皓元医药",
                        "诺泰生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-16",
                "original_text": "智通港股通占比异动统计|8月16日",
                "features": {
                    "keywords": [
                        "港股通",
                        "占比异动",
                        "统计"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}